Abstract: The present invention discloses a foam material for fire prevention and extinguishing and a preparation method and a use thereof. The foam material for fire prevention and extinguishing comprises the following raw materials in parts by weight: 2-4 parts of foaming agent, 2.5-3.5 parts of foam stabilizer, 10-16 parts of expandable graphite, and 100 parts of water. The foam material for fire prevention and extinguishing has a foaming multiple up to 15-30 times, a viscosity of only 700 mPa·s at a flow state, and the foam could be stable for more than 12 h. After being transported to an ignition point of the goaf via the mine grouting pipeline, the foam material for fire prevention and extinguishing can spread and pile in a large area in the goaf, and thus cover and plug the float coal at low and high places, with a piling height above 1.5 m.

Abstract: The present invention discloses a foam material for fire prevention and extinguishing and a preparation method and a use thereof. The foam material for fire prevention and extinguishing comprises the following raw materials in parts by weight: 2-4 parts of foaming agent, 2.5-3.5 parts of foam stabilizer, 10-16 parts of expandable graphite, and 100 parts of water. The foam material for fire prevention and extinguishing has a foaming multiple up to 15-30 times, a viscosity of only 700 mPa·s at a flow state, and the foam could be stable for more than 12 h. After being transported to an ignition point of the goaf via the mine grouting pipeline, the foam material for fire prevention and extinguishing can spread and pile in a large area in the goaf, and thus cover and plug the float coal at low and high places, with a piling height above 1.5 m.

Abstract: This invention discloses the use of aza-tryptanthrin derivatives as an IDO1 and/or TDO inhibitors, and the derivatives are represented by the general Formula (I). The compounds represented by the Formula (I) have inhibitory effects on indoleamine-2,3-dioxygenase 1 (IDO1) and/or tryptophan-2,3-dioxygenase (TDO), and can be used for treating diseases having the pathological features of IDO1 and/or TDO-mediated tryptophan metabolism, including but not limited to tumors, autoimmune disease, infectious diseases, Alzheimer's disease, depression, anxiety.

Abstract: This invention discloses the use of aza-tryptanthrin derivatives as an IDO1 and/or TDO inhibitors, and the derivatives are represented by the general Formula (I). The compounds represented by the Formula (I) have inhibitory effects on indoleamine-2,3-dioxygenase 1 (IDO1) and/or tryptophan-2,3-dioxygenase (TDO), and can be used for treating diseases having the pathological features of IDO1 and/or TDO-mediated tryptophan metabolism, including but not limited to tumors, autoimmune disease, infectious diseases, Alzheimer's disease, depression, anxiety.